The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses

Journal of Experimental Medicine

Volumn 209, Issue 8, 2012, Pages 1427-1435

  Pachynski, Russell K ^a,b   Zabel, Brian A ^b   Kohrt, Holbrook E ^a   Tejeda, Nicole M ^a,b   Monnier, Justin ^a,b   Swanson, Christina D ^a,b   Holzer, Alison K ^a,b   Gentles, Andrew J ^a   Sperinde, Gizette V ^a,b   Edalati, Abdolhossein ^a,b   Hadeiba, Husein A ^a,b   Alizadeh, Ash A ^a   Butcher, Eugene C ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; CHEMOKINE LIKE RECEPTOR 1 PROTEIN; CHEMOKINE RECEPTOR; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR IMMUNITY;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHEMOKINES; CHEMOTACTIC FACTORS; DENDRITIC CELLS; DOWN-REGULATION; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, CHEMOKINE; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 84866443091     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20112124     Document Type: Article

References (34)

1. Apte, R.N., S. Dotan, M. Elkabets, M.R. White, E. Reich, Y. Carmi, X. Song, T. Dvozkin, Y. Krelin, and E. Voronov. 2006. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25: 387-408. http://dx.doi.org/10 .1007/s10555-006-9004-4
2. Bierie, B., and H.L. Moses. 2010. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 21: 49-59. http://dx.doi.org/10.1016/j.cytogfr.2009.11.008
3. Chakravarti, N., R. Lotan, A.H. Diwan, C.L. Warneke, M.M. Johnson, and V.G. Prieto. 2007. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin. Cancer Res. 13: 4817-4824. http://dx.doi.org/10.1158/1078-0432.CCR-06-3026
4. Curran, M.A., W. Montalvo, H. Yagita, and J.P. Allison. 2010. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc. Natl. Acad. Sci. USA. 107: 4275-4280. http://dx.doi.org/10.1073/pnas.0915174107
5. Edgar, R., M. Domrachev, and A.E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210. http://dx.doi.org/10.1093/nar/30.1.207
6. Ernst, M.C., I.D. Haidl, L.A. Zúñiga, H.J. Dranse, J.L. Rourke, B.A. Zabel, E.C. Butcher, and C.J. Sinal. 2012. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology. 153: 672-682. http://dx.doi.org/ 10.1210/en.2011-1490
7. Fernandez-Ranvier, G.G., J. Weng, R.F. Yeh, E. Khanafshar, I. Suh, C. Barker, Q.Y. Duh, O.H. Clark, and E. Kebebew. 2008. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch. Surg. 143:841-846, discussion: 846. http://dx.doi.org/10.1001/archsurg.143.9.841
8. Graham, K.L., B.A. Zabel, S. Loghavi, L.A. Zuniga, P.P. Ho, R.A. Sobel, and E.C. Butcher. 2009. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J. Immunol. 183: 6717-6723. http://dx.doi.org/10.4049/jimmunol.0803435
9. Hadeiba, H., T. Sato, A. Habtezion, C. Oderup, J. Pan, and E.C. Butcher. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9: 1253-1260. http://dx.doi.org/10.1038/ni.1658
10. Klopper, J.P., V. Sharma, A. Berenz, W.R. Hays, M. Loi, U. Pugazhenthi, S. Said, and B.R. Haugen. 2009. Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression. Mol. Cancer. 8:16. http://dx.doi.org/10.1186/1476-4598-8-16
11. Majeti, R., M.P. Chao, A.A. Alizadeh, W.W. Pang, S. Jaiswal, K.D. Gibbs Jr., N. van Rooijen, and I.L. Weissman. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 138: 286-299. http://dx.doi.org/10.1016/j.cell.2009.05.045
12. Maldonado, R.A., and U.H. von Andrian. 2010. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 108: 111-165. http://dx.doi.org/10.1016/B978-0-12-380995-7.00004-5
13. Muruganandan, S., S.D. Parlee, J.L. Rourke, M.C. Ernst, K.B. Goralski, and C.J. Sinal. 2011. Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J. Biol. Chem. 286: 23982-23995. http://dx.doi .org/10.1074/jbc.M111.220491
14. Nagaraj, S., and D.I. Gabrilovich. 2010. Myeloid-derived suppressor cells in human cancer. Cancer J. 16: 348-353. http://dx.doi.org/10.1097/PPO .0b013e3181eb3358
15. Nagpal, S., S. Patel, H. Jacobe, D. DiSepio, C. Ghosn, M. Malhotra, M. Teng, M. Duvic, and R.A. Chandraratna. 1997. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109: 91-95. http://dx.doi.org/10.1111/1523-1747.ep12276660
16. Ostrand-Rosenberg, S. 2010. Myeloid-derived suppressor cells: more mech-anisms for inhibiting antitumor immunity. Cancer Immunol. Immunother. 59: 1593-1600. http://dx.doi.org/10.1007/s00262-010-0855-8
17. Parolini, S., A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, et al. 2007. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 109: 3625-3632. http://dx.doi.org/10.1182/blood-2006-08-038844
18. Pivarcsi, A., A. Müller, A. Hippe, J. Rieker, A. van Lierop, M. Steinhoff, S. Seeliger, R. Kubitza, U. Pippirs, S. Meller, et al. 2007. Tumor immune escape by the loss of homeostatic chemokine expression. Proc. Natl. Acad. Sci. USA. 104: 19055-19060. http://dx.doi.org/10.1073/pnas.0705673104
19. Sato, E., S.H. Olson, J. Ahn, B. Bundy, H. Nishikawa, F. Qian, A.A. Jungbluth, D. Frosina, S. Gnjatic, C. Ambrosone, et al. 2005. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA. 102: 18538-18543. http://dx.doi.org/10.1073/pnas.0509182102
20. Schreiber, R.D., L.J. Old, and M.J. Smyth. 2011. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 331: 1565-1570. http://dx.doi.org/10.1126/science.1203486
21. Segditsas, S., O. Sieber, M. Deheragoda, P. East, A. Rowan, R. Jeffery, E. Nye, S. Clark, B. Spencer-Dene, G. Stamp, et al. 2008. Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice. Hum. Mol. Genet. 17: 3864-3875. http://dx.doi.org/10.1093/hmg/ddn286
22. Sethi, G., B. Sung, and B.B. Aggarwal. 2008. TNF: a master switch for inflammation to cancer. Front. Biosci. 13: 5094-5107. http://dx.doi.org/10.2741/3066
23. Shistik, G., A.V. Prakash, N.A. Fenske, and L.F. Glass. 2007. Treatment of locally metastatic melanoma: a novel approach. J. Drugs Dermatol. 6:830-832
24. Skrzeczyńska-Moncznik, J., A. Stefanska, B.A. Zabel, M. Kapińska-Mrowiecka, E.C. Butcher, and J. Cichy. 2009. Chemerin and the recruitment of NK cells to diseased skin. Acta Biochim. Pol. 56:355-360
25. Stamey, T.A., J.A. Warrington, M.C. Caldwell, Z. Chen, Z. Fan, M. Mahadevappa, J.E. McNeal, R. Nolley, and Z. Zhang. 2001. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J. Urol. 166: 2171-2177. http://dx.doi.org/10.1016/S0022-5347(05)65528-0
26. Su, A.I., T. Wiltshire, S. Batalov, H. Lapp, K.A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA. 101: 6062-6067. http://dx.doi.org/10.1073/pnas.0400782101
27. Winnepenninckx, V., V. Lazar, S. Michiels, P. Dessen, M. Stas, S.R. Alonso, M.F. Avril, P.L. Ortiz Romero, T. Robert, O. Balacescu, et al; Melanoma Group of the European Organization for Research and Treatment of Cancer. 2006. Gene expression profiling of primary cuta-neous melanoma and clinical outcome. J. Natl. Cancer Inst. 98: 472-482. http://dx.doi.org/10.1093/jnci/djj103
28. Wittamer, V., J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brézillon, R. Tyldesley, C. Blanpain, M. Detheux, et al. 2003. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198: 977-985. http://dx.doi.org/10.1084/jem.20030382
29. Xu, L., S.S. Shen, Y. Hoshida, A. Subramanian, K. Ross, J.P. Brunet, S.N. Wagner, S. Ramaswamy, J.P. Mesirov, and R.O. Hynes. 2008. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6: 760-769. http://dx.doi.org/10.1158/1541-7786.MCR-07-0344
30. Zabel, B.A., A.M. Silverio, and E.C. Butcher. 2005. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J. Immunol. 174:244-251
31. Zabel, B.A., L. Zuniga, T. Ohyama, S.J. Allen, J. Cichy, T.M. Handel, and E.C. Butcher. 2006. Chemoattractants, extracellular proteases, and the integrated host defense response. Exp. Hematol. 34: 1021-1032. http://dx.doi.org/10.1016/j.exphem.2006.05.003
32. Zabel, B.A., S. Nakae, L. Zúñiga, J.Y. Kim, T. Ohyama, C. Alt, J. Pan, H. Suto, D. Soler, S.J. Allen, et al. 2008. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J. Exp. Med. 205: 2207-2220. http://dx.doi.org/10.1084/jem.20080300
33. Zheng, Y., S. Luo, G. Wang, Z. Peng, W. Zeng, S. Tan, Y. Xi, and J. Fan. 2008. Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma. Eur. J. Dermatol. 18:638-641
34. Zitvogel, L., A. Tesniere, and G. Kroemer. 2006. Cancer despite immuno-surveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6:715-727. http://dx.doi.org/10.1038/nri1936